Literature DB >> 15937562

Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3).

Chia-Nan Chen, Coney P C Lin, Kuo-Kuei Huang, Wei-Cheng Chen, Hsin-Pang Hsieh, Po-Huang Liang, John T-A Hsu.   

Abstract

SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CL(Pro)) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product library consisting of 720 compounds for inhibitory activity against 3CL(Pro). Two compounds in the library were found to be inhibitive: tannic acid (IC(50) = 3 microM) and 3-isotheaflavin-3-gallate (TF2B) (IC(50) = 7 microM). These two compounds belong to a group of natural polyphenols found in tea. We further investigated the 3CL(Pro)-inhibitory activity of extracts from several different types of teas, including green tea, oolong tea, Puer tea and black tea. Our results indicated that extracts from Puer and black tea were more potent than that from green or oolong teas in their inhibitory activities against 3CL(Pro). Several other known compositions in teas were also evaluated for their activities in inhibiting 3CL(Pro). We found that caffeine, (-)-epigallocatechin gallte (EGCg), epicatechin (EC), theophylline (TP), catechin (C), epicatechin gallate (ECg) and epigallocatechin (EGC) did not inhibit 3CL(Pro) activity. Only theaflavin-3,3'-digallate (TF3) was found to be a 3CL(Pro) inhibitor. This study has resulted in the identification of new compounds that are effective 3CL(Pro) inhibitors.

Entities:  

Year:  2005        PMID: 15937562      PMCID: PMC1142193          DOI: 10.1093/ecam/neh081

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


Introduction

Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus, SARS coronavirus (SARS-CoV) (1,2). From November 1, 2002 to June 18, 2003, a total of 8465 probable SARS cases were reported to the World Health Organization from 29 countries, and 801 people died from this disease. The case–fatality proportion was ∼10%. Although the spread of the virus has been averted, the re-emergence of SARS is still in question (3–6). Like other related coronaviruses, SARS-CoV is an enveloped virus containing single-stranded RNA of positive polarity. Coronaviruses have the largest genomes known (∼30 kb) among RNA viruses [7]. The genome of SARS-CoV comprises one open reading frame (ORF) encoding two overlapping replicase polyproteins, polyprotein-1a (pp1a, ∼450 kDa) and poplyprotein-1ab (pp1ab, ∼750 kDa), responsible for virus replication (7). The rest of the genome comprises at least five ORFs encoding structural proteins and other genes with putative functions (8,9). Proteolytic processing, especially the processing of replicase polyproteins, is one of the crucial steps in the life cycle of many positive-stranded RNA viruses, including coronaviruses. All coronaviruses encode a papline-like protease (PLP) and a chymotrypsin-like (3CLPro) protease for proteolytic procession during virus maturation (10). Studies on other coronaviruses have shown that the PLP protein cleaves at no less than two sites on the pp1a polyprotein and that the 3CLPro protease cleaves at least 11 inter-domain sites on the pp1a and pp1ab polyproteins [7]. Thus, the 3CLPro protease of SARS-CoV has been considered as an important molecular target for anti-SARS-CoV drug discovery and developments. In this study, after screening of a natural product library and further confirmation, we found that SARS-3CLPro could be inhibited by compounds that are abundant in teas. We also examined crude extracts from various teas and a panel of representative natural products in teas for their inhibitory activities against SARS-3CLPro.

Methods

Preparation of SARS-CoV 3CLPro

Total RNA extracted from a throat swab of a SARS patient was provided by the Center for Disease Control (CDC), Taipei, Taiwan. All RNA samples were handled under bio-safety level 2 (BSL2) regulations. Two primers, 5′-GGCGGAATTCGCCTCTACCAACCACCACAGA-3′ and 5′-GGCGGAATTCA AAGCATCCAATGATGAGTGCC-3′, were used for reverse transcription–polymerase chain reaction (RT–PCR) to synthesize the cDNA of SARS-3CLPro using Ready-to-Go RT–PCR Beads (Amersham Biosciences, Piscataway, NJ) according to the manufacturer's protocol. The PCR cycle used for the amplification of cDNA of SARS-3CLPro was as follows: 94°C for 5 min, 25 cycles of 94°C for 1 min, 58°C for 3 min, 72°C for 2 min and 72°C for 10 min. A full-length 3CLPro of SARS coronavirus was successfully expressed in Escherichia coli as a glutathione S-transferase (GST) fusion protein. Following cleavage by thrombin, 3CLPro was purified to homogeneity. A 15mer peptide with sequence H2N-SITSAVLQSGFRKMA-COOH corresponding to an autocleavage site of the SARS-3CLPro was synthesized and used for protease cleavage activity assay. The highly purified protein was shown by high-performance liquid chromatography (HPLC) analysis to exhibit proteolytic activity in trans.

Compound Collection

The Pure Natural Products Library used to screen for 3CLPro inhibition was obtained from MicroSource Discovery Systems, Inc., Gaylordsville, CT. It consists of a unique collection of 720 pure natural products. The collection includes simple and complex oxygen heterocycles, alkaloids, sequiterpenes, diterpenes, pentacyclic triterpenes, sterols and many other diverse representatives. Initially, 10 different compounds were pooled, and the mixtures were tested for their inhibitory activities against SARS-3CLPro. Positive pools were then deconvoluted and single pure compounds that were able to inhibit >50% of peptide cleavage at 10 µM were scored as hits. Other compounds were obtained from Sigma (St Louis, MO). Theaflavin (TF1), TF2 [a mixture of TF-2A (theaflavin-3-gallate) and TF-2B (theaflavin-3′-gallate)] and theaflavin-3,3′-digallate (TF3) were kind gifts from Dr Yu-Chih Liang, School of Medical Technology, Taipei Medical University, Taipei, Taiwan, ROC.

Preparation of Crude Extracts from Oolong Tea, Green Tea, Black Tea and Puer Tea

Tea liquors were prepared from oolong tea, green tea, black tea and Puer tea (also called pu-er or pu-erh) samples as 2% (w/v) tea solutions. The water extracts of four different types of tea leaves were prepared by shaking for 10 min in boiling hot water in thermal flasks. The extracts were then filtered through a Millex-GS 0.22 µm filter (Millipore, Malsheim, France) to remove particulate matter. The water extracts were then evaporated under reduced pressure to obtain viscous masses. These materials were evaluated for their inhibitory activities against SARS-3CLPro.

Inhibition of Protease Activity of SARS-3CLPro by HPLC Assay

A general cysteine protease inhibitor, N-ethylmaleimide (NEM, protease inhibitor as positive control), was obtained from Sigma (St Louis, MO). This compound was tested for its inhibitory activities against SARS-3CLPro in the peptide cleavage assay. The activities of the proteases were measured in the absence or presence of different concentrations of these general inhibitors. The enzyme (2 µM) was pre-incubated with chemicals for 30 min. Peptide was then added at 100 µM to the reaction, and mixtures were incubated at 37°C for 1 h. The potency of the inhibitors was calculated. The HPLC analysis condition is: a C18 RP guard column (250 × 4.6 mm × 5 µm, Agilent Zorbax Extend). This method was chosen because it gave the best resolution among several methods that were tested. The column temperature was ambient, and the elution (0.8 ml/min) was performed using a solvent system comprising solvents A [10 MM NH4OAc, 0.1% trifluoroacetic acid (TFA)] and B (acetonitrile, 0.1% TFA) mixed using a gradient starting with 100% A, linearly decreasing to 10% A in 8 min, to 100% A in 16 min, and held at 100% A for 23 min. The injection volume was 40 ml. The UV detector was set at 214 nm.

Proteolytic Activity of SARS-3CLPro by Fluorogenic Substrate Peptide Assay

The development of a fluorescent protease activity assay has been reported previously (7). The enhanced fluorescence due to cleavage of the fluorogenic substrate peptide (Dabcyl-KTSAVLQSGFRKME-Edans) catalyzed by the protease was monitored at 538 nm with excitation at 355 nm using a fluorescence plate reader (Fluoroskan Ascent from ThermoLabsystems, Sweden). The fluorimetric assay was used to determine the IC50 of identified inhibitors on SARS 3CLPro activity. The protease was stored in the buffer containing 12 mM TrisHCl (pH 7.5), 120 mM NaCl, 0.1 mM EDTA, 7.5 mM 2-mercaptoethanol and 1 mM dithiothreitol (DTT) at −70°C before use.

Results

Screening of a 720 Compound Library Against 3CLPro Activity by HPLC Assay

The spectrum collection, a library of 720 drugs and natural products, was screened for 3CLPro inhibitory activity. A flowchart of the screening procedure is shown in Fig. 1. Initially, 10 different compounds were pooled, and the 72 mixtures were then tested for their inhibitory activities against SARS-3CLPro. The HPLC assay was used in the primary screening because many compounds in the library are chromogenic. Single compounds in the positive pools were then evaluated for their activities. Two compounds, tannic acid and TF2B, were found to be active against 3CLPro (Fig. 2). Tannic acid is a water-soluble polyphenol present in plant food such as tea, red wine, beer and nuts. In addition, tea polyphenols and many tannin components are thought to be anticarcinogenic (14,15).

Flowchart of the screening of the compound library and tea compositions.

Inhibition of 3CL Pro activity by HPLC assay. Injection of 40 µl of incubation samples for C18 reverse phase column analysis. The substrate or product fragment peaks were analyzed by HPLC with UV absorbance detection at 214 nm. The HPLC system is described in Methods.

Evaluation of Tea Extracts and Pure Components from Teas for Their Inhibition of 3CLPro Activity

Since many other polyphenols related to tannic acid and TF2B are also present in various kinds of teas, we decided to examine the inhibition of activity by various tea extracts and several well known pure ingredients present in teas. Thus, water extracts from different types of teas were prepared and evaluated for their inhibitory activities against 3CLPro. As shown in Table 1, extracts from black and Puer teas inhibited 3CLPro activity while those from green or oolong teas did not. We further tested the possible involvement of several known ingredients present in teas, including caffeine, theophylline, catechin (C), epigallocatechin (EGC), (—)-epigallocatechin gallte (EGCg), epicatechin (EC), epicatechin gallate (ECg), TF1, TF2, TF2B, tannic acid and TF3. As shown in Table 1, the results showed that methylxanthine (caffeine and theophylline) did not influence 3CLPro activity; catechins, including C, EC, ECg, EGC and EGCg, present in green tea (unfermented) and oolong tea (partial fermented) also did not inhibit 3CLPro activity. Our results indicated that tannic acid, TF2B and TF3 are 3CLPro inhibitors as revealed by the fluorogenic substrate assay (Fig. 3). TF2A was not tested because of its unavailability.

Inhibition of SARS 3CLPro activity by natural products

Compound libraryIC50 (µM)

3-Isotheaflavin-3-gallate (TF2B)7
Tannic acid3

Tea extractIC50 (µg/ml)

Oolong tea125
Green tea125
Black tea70
Puer tea25

Other compositions in green teaIC50 (µM)

Caffeine100
Theophylline100
Catechin (C)100
Epigallocatechin (EGC)100
(–)-Epigallocatechin gallte (EGCg)100
Epicatechin (EC)100
Epicatechin gallate (ECg)100

Theaflavin composition in black teaIC50 (µM)

Theaflavin (TF1)56
Theaflavin-3-gallate,TF-2a and43
Theaflavin-3′ -gallate,TF-2b mixture (TF2)
Theaflavin-3,3′ -digallate (TF3)9.5

Inhibition of 3CLPro activity by fluorogenic substrate peptide assay. Inhibition of 3CLPro activity by tannic acid, TF1, TF2B, TF3 and EGCg. The enhanced fluorescence due to cleavage of the fluorogenic substrate peptide catalyzed by the protease was monitored at 538 nm with exicitation at 355 nm using a fluorescence plate reader. The determining assay is described in Methods.

TF2B and TF3 as Potent Agents Against 3CLPro Inhibitory Activity

The natural product screened library consisted of simple and complex oxygen heterocycles, alkaloids, sequiterpenes, diterpenes, pentacyclic triterpenes, sterols and many other diverse representatives. Numerous black tea polyphenols (especially those of TF1, TF2 and TF3) were found to inhibit 3CLPro. In black tea, TF3 was the most abundant (1.05%) followed by TF2A (0.34%), TF2B (0.11%) and TF1 (0.08%) (16). It is interesting to note that TF3 contained two gallate groups attached to the 3,3′ positions as shown in Fig. 4b. TF2A and TF2B, on the other hand, consisted of only one gallate group attached either to the 3 or the 3′ positions, respectively (Fig. 4b). In contrast, no gallate group was attached to TF1. Results in Table 1, indicating that the gallate group attached to the 3′ position to TF2B and TF3, might be important for interaction with the 3CLPro active site. EC, EGCg, ECG and EGC were much less active (IC50 ≥ 100 µM) than theaflavins.

Chemical structures of tannic acid, catechins and TFs.

Discussion

Human coronaviruses (HCoVs) are major causes of upper respiratory tract illness in animals including humans. It has been demonstrated that a novel coronavirus causes SARS. The main protease, frequently called 3C-like protease (3CLPro), has been identified as an attractive drug target (17). Of the 720 natural products screened in this study, tannic acid (Fig. 4a) and TF2B were identified using the HPLC proteolytic assay to inhibit 50% of the proteolytic acitivity of 3CLPro at concentrations ≤10 µM. Both tannic acid and TF2B belong to the group of natural polyphenols found in teas. Low concentrations of tannic acid were found to inhibit proteases including tissue-type plasminogen activator, urokinase-type plasminogen activator and plasmin activity [13]. Over 300 different kinds of tea are now produced, but they are classified into three main forms: green tea is manufactured by drying fresh tea leaves, with emphasis on the prevention of oxidation of the tea polyphenols during the manufacturing process. In contrast, the manufacture of black tea is characterized by a high degree of fermentation, which produces a series of chemical condensations among the ingredients present in tea. Oolong tea is partially fermented, and the tea compositions are more similar to those found in green tea (18). In evaluating different types of tea, we found that extracts from several different types of tea, including Puer and black tea, could inhibit 3CLPro activity while green or oolong tea could not. However, the chemical composition in Puer tea is very complex and it is difficult to isolate pure ingredients for structural identification. Purification and identification of Puer tea ingredients should be carried out in a separate study. We next examined whether other well-known ingredients present in tea could also inhibit 3CLPro activity. We found that methylxanthine (caffeine and theophylline) and catechins (EGCg, EC, C, ECg and EGC) were not able to inhibit 3CLPro activity at concentrations up to 100 µM (Table 1). However, TF1, TF2 and TF3 were more potent 3CLPro inhibitors than catechins in green tea. During the fermentation step in the production of black tea, most of the catechins are oxidized and condensed into theaflavins through dimerization and into thearubigins through polymerization. Green tea contains ∼30% of catechins (dry mass base) while black tea contains ∼9% of catechins and 4% of theaflavins (19). In another study, Leung et al. (16) reported that TF3 was the most abundant (1.05%) theaflavin in black tea followed by TF2A (0.34%), TF2B (0.11%) and TF1 (0.08%). Tannic acid is a class of polyphenolic in plants but the quantification of its levels in green or black tea is difficult because tannic acid constitutes a wide range of polymers with mol. wts of 500–3000 Da. It is interesting to note that TF2B and TF3 are more potent inhibitors of 3CLPro than TF1 (Table 1). Unlike TF2B and TF3, TF1 does not contain a gallate group (Fig. 4b). Thus, the addition of a gallate group attached at the 39 position to TF2B and TF3 might be important for their inhibitory activity against 3CLPro. These results suggest that TF2B and TF3 might be good starting points for the design of more active inhibitors for the 3CLPro encoded by SARS-CoV. Finally, this study has identified three compounds (TF2B, TF3 and tannic acid) that are effective 3CLPro inhibitors (IC50 ≤10 µM). These compounds are abundant in the extract of black tea (16,19). Black tea is a popular beverage in the world. Results from this study warrant further investigation to examine the effect of these natural products in inhibition of SARS-CoV replication in cell culture. Clark et al. reported that theaflavins extracted from black tea were able to neutralize bovine coronavirus and rotavirus infections (20). Thus, it will be very interesting to evaluate, in a separate study, whether drinking black tea can prevent or alleviate the infection of an enteric form of coronavirus since SARS-CoV is known to actively replicate in the intestinal tract (21).
  20 in total

1.  Virology. The SARS coronavirus: a postgenomic era.

Authors:  Kathryn V Holmes; Luis Enjuanes
Journal:  Science       Date:  2003-05-30       Impact factor: 47.728

2.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

3.  Processing of the human coronavirus 229E replicase polyproteins by the virus-encoded 3C-like proteinase: identification of proteolytic products and cleavage sites common to pp1a and pp1ab.

Authors:  J Ziebuhr; S G Siddell
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Mutational analysis of the active centre of coronavirus 3C-like proteases.

Authors:  Annette Hegyi; Agnes Friebe; Alexander E Gorbalenya; John Ziebuhr
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

5.  Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.

Authors:  I A Taitzoglou; M Tsantarliotou; I Zervos; D Kouretas; N A Kokolis
Journal:  Reproduction       Date:  2001-01       Impact factor: 3.906

6.  Proteolytic processing at the amino terminus of human coronavirus 229E gene 1-encoded polyproteins: identification of a papain-like proteinase and its substrate.

Authors:  J Herold; A E Gorbalenya; V Thiel; B Schelle; S G Siddell
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  The Genome sequence of the SARS-associated coronavirus.

Authors:  Marco A Marra; Steven J M Jones; Caroline R Astell; Robert A Holt; Angela Brooks-Wilson; Yaron S N Butterfield; Jaswinder Khattra; Jennifer K Asano; Sarah A Barber; Susanna Y Chan; Alison Cloutier; Shaun M Coughlin; Doug Freeman; Noreen Girn; Obi L Griffith; Stephen R Leach; Michael Mayo; Helen McDonald; Stephen B Montgomery; Pawan K Pandoh; Anca S Petrescu; A Gordon Robertson; Jacqueline E Schein; Asim Siddiqui; Duane E Smailus; Jeff M Stott; George S Yang; Francis Plummer; Anton Andonov; Harvey Artsob; Nathalie Bastien; Kathy Bernard; Timothy F Booth; Donnie Bowness; Martin Czub; Michael Drebot; Lisa Fernando; Ramon Flick; Michael Garbutt; Michael Gray; Allen Grolla; Steven Jones; Heinz Feldmann; Adrienne Meyers; Amin Kabani; Yan Li; Susan Normand; Ute Stroher; Graham A Tipples; Shaun Tyler; Robert Vogrig; Diane Ward; Brynn Watson; Robert C Brunham; Mel Krajden; Martin Petric; Danuta M Skowronski; Chris Upton; Rachel L Roper
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

8.  Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins.

Authors:  Marilisa Leone; Dayong Zhai; Sina Sareth; Shinichi Kitada; John C Reed; Maurizio Pellecchia
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

9.  The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond.

Authors:  J Ziebuhr; V Thiel; A E Gorbalenya
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

10.  An in vitro study of theaflavins extracted from black tea to neutralize bovine rotavirus and bovine coronavirus infections.

Authors:  K J Clark; P G Grant; A B Sarr; J R Belakere; C L Swaggerty; T D Phillips; G N Woode
Journal:  Vet Microbiol       Date:  1998-10       Impact factor: 3.293

View more
  75 in total

1.  Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease.

Authors:  Shao-Chun Wang; Yeh Chen; Yu-Chuan Wang; Wei-Jan Wang; Chia-Shin Yang; Chia-Ling Tsai; Mei-Hui Hou; Hsiao-Fan Chen; Yi-Chun Shen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.

Authors:  Mohamed Haddad; Roger Gaudreault; Gabriel Sasseville; Phuong Trang Nguyen; Hannah Wiebe; Theo Van De Ven; Steve Bourgault; Normand Mousseau; Charles Ramassamy
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

Review 3.  An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge.

Authors:  Doha H Abou Baker
Journal:  Toxicol Rep       Date:  2022-03-14

Review 4.  New perspectives on natural flavonoids on COVID-19-induced lung injuries.

Authors:  Fernanda Paula R Santana; Fernanda Thevenard; Kaio S Gomes; Laura Taguchi; Niels Olsen S Câmara; Roberta S Stilhano; Rodrigo P Ureshino; Carla Maximo Prado; João Henrique Ghilardi Lago
Journal:  Phytother Res       Date:  2021-04-29       Impact factor: 6.388

5.  Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.

Authors:  Arun K Ghosh; Kai Xi; Michael E Johnson; Susan C Baker; Andrew D Mesecar
Journal:  Annu Rep Med Chem       Date:  2007-02-01       Impact factor: 1.059

Review 6.  Antiviral Activity Exerted by Natural Products against Human Viruses.

Authors:  Maria Musarra-Pizzo; Rosamaria Pennisi; Ichrak Ben-Amor; Giuseppina Mandalari; Maria Teresa Sciortino
Journal:  Viruses       Date:  2021-05-04       Impact factor: 5.048

Review 7.  Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.

Authors:  Mohammad Amin Khazeei Tabari; Amin Iranpanah; Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

Review 8.  Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.

Authors:  Seyed Abdulmajid Ayatollahi; Javad Sharifi-Rad; Patrick Valere Tsouh Fokou; Gail B Mahady; Hafiz Ansar Rasul Suleria; Shivani Krishna Kapuganti; Kundlik Gadhave; Rajanish Giri; Neha Garg; Rohit Sharma; Daniel Ribeiro; Célia F Rodrigues; Željko Reiner; Yasaman Taheri; Natália Cruz-Martins
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

Review 9.  Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.

Authors:  Susana A Llivisaca-Contreras; Jaime Naranjo-Morán; Andrea Pino-Acosta; Luc Pieters; Wim Vanden Berghe; Patricia Manzano; Jeffrey Vargas-Pérez; Fabian León-Tamariz; Juan M Cevallos-Cevallos
Journal:  Molecules       Date:  2021-07-05       Impact factor: 4.411

Review 10.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.